Key Takeaways
- Ultrasound-guided myofascial hydrodissection technique (UMHT) and trigger point injection of lidocaine (TPI) are both effective in managing myofascial pain syndrome (MPS) of the upper trapezius.
- Both UMHT and TPI showed significant reductions in pain and improvements in function over a 12-week follow-up period.
- There was no significant difference in efficacy or safety between UMHT and TPI, making them both viable treatment options for MPS.
Exploring Efficacy and Safety
Myofascial pain syndrome (MPS) is a common chronic musculoskeletal disorder characterized by myofascial trigger points (MTrPs), which can cause localized muscle pain and restricted range of motion. In a recent randomized clinical trial, researchers set out to compare the efficacy and safety of ultrasound-guided myofascial hydrodissection technique (UMHT) with trigger point injection of lidocaine (TPI) in patients with MPS of the upper trapezius.
Study Design and Outcomes
The study, conducted at the rehabilitation medicine center of West China Hospital, included 41 patients who were assigned to either the UMHT group or the TPI group. The primary outcomes were measured using the Visual Analog Scale (VAS), the short-form McGill pain questionnaire (SF-MPQ), and the neck disability index (NDI) at multiple time points over a 12-week follow-up period. The results showed significant reductions in pain and improvements in function for both treatment groups, with no statistically significant difference between UMHT and TPI.
Implications for Treatment
These findings suggest that both UMHT and TPI are effective and safe options for managing MPS of the upper trapezius. Patients experiencing chronic muscle pain and dysfunction in this region may benefit from either treatment approach, depending on individual preferences and healthcare provider recommendations. The ability to compare the two methods in a clinical trial provides valuable insight for clinicians seeking evidence-based interventions for MPS.
Future Research and Clinical Practice
Further research may explore the long-term effects of UMHT and TPI on MPS, as well as potential differences in patient preferences, cost-effectiveness, and healthcare resource utilization. Clinicians should consider the findings of this study when developing treatment plans for patients with MPS, taking into account individual factors such as pain severity, functional limitations, and treatment goals.